Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer
Authors
Keywords
Epidermal growth factor receptor, Tyrosine kinase inhibitors, Circulating cell-free tumor DNA, MicroRNAs, Proteomics, Circulating tumor cells, Non-small-cell lung cancer
Journal
Journal of Hematology & Oncology
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-07-30
DOI
10.1186/s13045-015-0193-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating microRNAs: potential biomarkers for common malignancies
- (2015) Samantha Khoury et al. Biomarkers in Medicine
- Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer
- (2015) T F Hansen et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma
- (2015) Bo Hou et al. CANCER BIOLOGY & THERAPY
- Molecular histology of lung cancer: From targets to treatments
- (2015) Steven L. Wood et al. CANCER TREATMENT REVIEWS
- Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy
- (2015) T. Mok et al. CLINICAL CANCER RESEARCH
- Proteomics in Cancer Biomarkers Discovery: Challenges and Applications
- (2015) Reem M. Sallam DISEASE MARKERS
- Novel ALK inhibitors in clinical use and development
- (2015) Chaitanya Iragavarapu et al. Journal of Hematology & Oncology
- microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/Akt pathway in hepatocellular carcinoma
- (2015) Zong-Tao Chai et al. Journal of Hematology & Oncology
- Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis
- (2015) Xun Yuan et al. Scientific Reports
- High Resolution Melting Analysis for Epidermal Growth Factor Receptor Mutations in Formalin-fixed Paraffin-embedded Tissue and Plasma Free DNA from Non-small Cell Lung Cancer Patients
- (2014) Chang-Wen Jing et al. Asian Pacific Journal of Cancer Prevention
- Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays
- (2014) Britta Weber et al. BMC CANCER
- Circulating Tumor DNA Is Effective for the Detection of EGFR Mutation in Non-Small Cell Lung Cancer: A Meta-analysis
- (2014) M. Qiu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- MicroRNA-34a overcomes HGF-mediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET
- (2014) Jian-Ya Zhou et al. CANCER LETTERS
- Clinical significance of pretreatment plasma biomarkers in advanced non-small cell lung cancer patients
- (2014) Shuai Wang et al. CLINICA CHIMICA ACTA
- Circulating tumor cells as promising novel biomarkers in solid cancers
- (2014) Evi S. Lianidou et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Predictive value of a serum-based proteomic test in non-small-cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitors: a meta-analysis
- (2014) Wei Sun et al. CURRENT MEDICAL RESEARCH AND OPINION
- MicroRNAs in Non-small Cell Lung Cancer: Current Status and Future Therapeutic Promises
- (2014) D. Cortinovis et al. CURRENT PHARMACEUTICAL DESIGN
- Molecular analysis of cell-free circulating DNA for the diagnosis of somatic mutations associated with resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
- (2014) Marzia Del Re et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Exploring microRNA-mediated alteration of EGFR signaling pathway in non-small cell lung cancer using an mRNA:miRNA regression model supported by target prediction databases
- (2014) Fengfeng Wang et al. GENOMICS
- Strategies for modern biomarker and drug development in oncology
- (2014) Alan D Smith et al. Journal of Hematology & Oncology
- Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery
- (2014) Wen-Tao Wang et al. Journal of Hematology & Oncology
- A phase I study of AST1306, a novel irreversible EGFR and HER2 kinase inhibitor, in patients with advanced solid tumors
- (2014) Jian Zhang et al. Journal of Hematology & Oncology
- MicroRNA-mediated regulation of KRAS in cancer
- (2014) Minlee Kim et al. Journal of Hematology & Oncology
- Nucleo-cytoplasmic transport as a therapeutic target of cancer
- (2014) Giovanni Luca Gravina et al. Journal of Hematology & Oncology
- Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents
- (2014) Kaushal Parikh et al. Journal of Hematology & Oncology
- Circulating miRNAs in cancer: from detection to therapy
- (2014) Wen-Tao Wang et al. Journal of Hematology & Oncology
- Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application
- (2014) Xun Yuan et al. Journal of Hematology & Oncology
- Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status
- (2014) Jean-Yves Douillard et al. Journal of Thoracic Oncology
- Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial
- (2014) Vanesa Gregorc et al. LANCET ONCOLOGY
- Development of a Highly Sensitive and Specific Method for Detection of Circulating Tumor Cells Harboring Somatic Mutations in Non-Small-Cell Lung Cancer Patients
- (2014) Frank Breitenbuecher et al. PLoS One
- Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment
- (2014) Antonio Marchetti et al. PLoS One
- Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer
- (2014) Kun Nie et al. TUMOR BIOLOGY
- Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis
- (2014) Jie Luo et al. Scientific Reports
- Clinical Utility of Circulating Tumor Cells in ALK-Positive Non-Small-Cell Lung Cancer
- (2014) Vincent Faugeroux et al. Frontiers in Oncology
- Determination of EGFR mutations in single cells microdissected from enriched lung tumor cells in peripheral blood
- (2013) Ran Ran et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Plasma MicroRNA Are Disease Response Biomarkers in Classical Hodgkin Lymphoma
- (2013) K. Jones et al. CLINICAL CANCER RESEARCH
- Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK-Positive Non–Small-Cell Lung Cancer
- (2013) Emma Pailler et al. JOURNAL OF CLINICAL ONCOLOGY
- The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies
- (2013) Xiaoqing Liu et al. JOURNAL OF CLINICAL PATHOLOGY
- Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping
- (2013) Hye-Ryoun Kim et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs
- (2013) Aamir Ahmad et al. Journal of Hematology & Oncology
- Serum Detection of Epidermal Growth Factor Receptor Gene Mutations Using Mutant-Enriched Sequencing in Chinese Patients with Advanced Non-Small Cell Lung Cancer
- (2013) B Jiang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Comparison of EGFR Signaling Pathway Somatic DNA Mutations Derived From Peripheral Blood and Corresponding Tumor Tissue of Patients with Advanced Non-Small-Cell Lung Cancer Using Liquidchip Technology
- (2013) Hui Zhang et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- A Retrospective Analysis of VeriStrat Status on Outcome of a Randomized Phase II Trial of First-Line Therapy with Gemcitabine, Erlotinib, or the Combination in Elderly Patients (Age 70 Years or Older) with Stage IIIB/IV Non–Small-Cell Lung Cancer
- (2013) Thomas E. Stinchcombe et al. Journal of Thoracic Oncology
- MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer
- (2013) Bing Li et al. LUNG CANCER
- microRNA expression profiles associated with survival, disease progression, and response to gefitinib in completely resected non-small-cell lung cancer with EGFR mutation
- (2013) Yi Shen et al. MEDICAL ONCOLOGY
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
- (2013) Isolde Summerer et al. Radiation Oncology
- Can Serum be Used for Analyzing the EGFR Mutation Status in Patients with Advanced Non-small Cell Lung Cancer?
- (2012) Seung Tae Kim et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma
- (2012) M. Ilie et al. ANNALS OF ONCOLOGY
- VeriStrat® has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib
- (2012) J L Kuiper et al. BRITISH JOURNAL OF CANCER
- SnapShot: Lung Cancer Models
- (2012) Anna F. Farago et al. CELL
- Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non-Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib
- (2012) E. A. Punnoose et al. CLINICAL CANCER RESEARCH
- Detection of EGFR Somatic Mutations in Non-Small Cell Lung Cancer (NSCLC) Using a Novel Mutant-Enriched Liquidchip (MEL) Technology
- (2012) Li Zhang et al. CURRENT DRUG METABOLISM
- Use of Research Biopsies in Clinical Trials: Are Risks and Benefits Adequately Discussed?
- (2012) Michael J. Overman et al. JOURNAL OF CLINICAL ONCOLOGY
- VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: Pooled analysis of SAKK19/05 and NTR528
- (2012) Oliver Gautschi et al. LUNG CANCER
- A phase II study of bevacizumab and erlotinib as initial treatment for metastatic non-squamous, non-small cell lung cancer with serum proteomic evaluation
- (2012) Wallace Akerley et al. LUNG CANCER
- Comparison of Epidermal Growth Factor Receptor Mutation Statuses in Tissue and Plasma in Stage IIV Non-Small Cell Lung Cancer Patients
- (2012) Xiao Zhao et al. RESPIRATION
- The detection of EGFR mutation status in plasma is reproducible and can dynamically predict the efficacy of EGFR-TKI
- (2012) Zhen Huang et al. Thoracic Cancer
- Quantitative Detection of EGFR Mutations in Circulating Tumor DNA Derived from Lung Adenocarcinomas
- (2011) K. Taniguchi et al. CLINICAL CANCER RESEARCH
- Screening for activating EGFR mutations in surgically resected nonsmall cell lung cancer
- (2011) K. B. Sriram et al. EUROPEAN RESPIRATORY JOURNAL
- Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
- (2011) Masahiro Fukuoka et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Molecular Marker Analyses ofEGFRandKRASFrom a Randomized, Placebo-Controlled Study of Erlotinib Maintenance Therapy in Advanced Non–Small-Cell Lung Cancer
- (2011) Wolfram Brugger et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidermal Growth Factor Receptor Mutation Status in Circulating Free DNA in Serum: From IPASS, a Phase III Study of Gefitinib or Carboplatin/Paclitaxel in Non-small Cell Lung Cancer
- (2011) Koichi Goto et al. Journal of Thoracic Oncology
- Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer
- (2010) Guo Jian et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- EGFR Mutations Detected in Plasma Are Associated with Patient Outcomes in Erlotinib Plus Docetaxel-Treated Non-small Cell Lung Cancer
- (2010) Philip C. Mack et al. Journal of Thoracic Oncology
- Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors
- (2010) Marie Brevet et al. LUNG CANCER
- Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non-Small Cell Lung Cancer Patients
- (2009) T. K.F. Yung et al. CLINICAL CANCER RESEARCH
- Noninvasive Detection of EGFR T790M in Gefitinib or Erlotinib Resistant Non-Small Cell Lung Cancer
- (2009) Y. Kuang et al. CLINICAL CANCER RESEARCH
- Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-cell lung cancer
- (2009) Chen He et al. INTERNATIONAL JOURNAL OF CANCER
- Epidermal Growth Factor Receptor Mutations in Plasma DNA Samples Predict Tumor Response in Chinese Patients With Stages IIIB to IV Non–Small-Cell Lung Cancer
- (2009) Hua Bai et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non–Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial
- (2009) Jean-Yves Douillard et al. JOURNAL OF CLINICAL ONCOLOGY
- A fast and convenient new technique to detect the therapeutic target, K-ras mutant, from peripheral blood in non-small cell lung cancer patients
- (2009) Der-An Tsao et al. LUNG CANCER
- VeriStrat® classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and bevacizumab
- (2009) David P. Carbone et al. LUNG CANCER
- Challenges of detecting EGFR T790M in gefitinib/erlotinib-resistant tumours
- (2008) Pasi A. Jänne LUNG CANCER
- Detection of Mutations inEGFRin Circulating Lung-Cancer Cells
- (2008) Shyamala Maheswaran et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started